Whitefort Capital Management, Lp Top Holdings and 13F Report (2024) About Whitefort Capital Management, LpInvestment ActivityWhitefort Capital Management, Lp has $219.61 million in total holdings as of September 30, 2024.Whitefort Capital Management, Lp owns shares of 18 different stocks, but just 7 companies or ETFs make up 80% of its holdings.Approximately 32.04% of the portfolio was purchased this quarter.About 11.39% of the portfolio was sold this quarter.This quarter, Whitefort Capital Management, Lp has purchased 23 new stocks and bought additional shares in 5 stocks.Whitefort Capital Management, Lp sold shares of 2 stocks and completely divested from 7 stocks this quarter.Largest Holdings Arbutus Biopharma $49,541,673Endeavor Group $28,560,000Roivant Sciences $27,592,140JOYY $20,507,419Genworth Financial $20,460,676 Largest New Holdings this Quarter Endeavor Group $28,560,000 HoldingINNOVATE CORP $1,184,485 Holding Largest Purchases this Quarter Endeavor Group 1,000,000 shares (about $28.56M)JOYY 354,932 shares (about $12.86M)CORE SCIENTIFIC INC NEW 885,000 shares (about $10.50M)Liquidia 927,546 shares (about $9.28M)Genworth Financial 990,000 shares (about $6.78M) Largest Sales this Quarter NextNav 247,823 shares (about $1.86M)OPKO Health 268,700 shares (about $400.36K) Sector Allocation Over TimeMap of 500 Largest Holdings ofWhitefort Capital Management, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorABUSArbutus Biopharma$49,541,6730.0%12,867,96722.6%MedicalEDREndeavor Group$28,560,000$28,560,000 ▲New Holding1,000,00013.0%Consumer DiscretionaryROIVRoivant Sciences$27,592,1400.0%2,391,00012.6%MedicalYYJOYY$20,507,419$12,862,736 ▲168.3%565,8789.3%Computer and TechnologyGNWGenworth Financial$20,460,676$6,781,500 ▲49.6%2,986,9609.3%FinanceLQDALiquidia$17,020,250$9,275,460 ▲119.8%1,702,0257.8%MedicalCORE SCIENTIFIC INC NEW$13,609,350$10,496,100 ▲337.1%1,147,5006.2%COMGSLGlobal Ship Lease$9,774,4470.0%366,7714.5%TransportationNNNextNav$9,383,704$1,856,194 ▼-16.5%1,252,8314.3%Business ServicesESPERION THERAPEUTICS INC NE$7,589,5100.0%8,000,0003.5%NOTE 4.000%11/1SABRE GLBL INC$4,970,0800.0%5,000,0002.3%NOTE 4.000% 4/1INNOVATE CORP$4,096,085$1,193,490 ▲41.1%12,218,0001.9%NOTE 7.500% 8/0MHLDMaiden$3,625,2490.0%2,048,1631.7%FinanceNNAVWNextNav$1,400,5580.0%482,9510.6%Computer and TechnologyINNOVATE CORP$1,184,485$1,184,485 ▲New Holding320,1310.5%COM NEWOPKOPKO Health$200,390$400,363 ▼-66.6%134,4900.1%MedicalTRINITY BIOTECH PLC$90,0920.0%81,9020.0%SPONS ADR NEWAEAEWAltEnergy Acquisition$2,0870.0%186,3150.0%Financial ServicesLSXMKThe Liberty SiriusXM Group$0$10,111,276 ▼-100.0%00.0%Consumer DiscretionaryESPREsperion Therapeutics$0$5,104,049 ▼-100.0%00.0%MedicalOMEXOdyssey Marine Exploration$0$2,678,676 ▼-100.0%00.0%TransportationCORE SCIENTIFIC INC NEW$0$2,172,500 ▼-100.0%00.0%*W EXP 01/23/202PBIPitney Bowes$0$1,897,380 ▼-100.0%00.0%Computer and TechnologyVATEINNOVATE$0$779,279 ▼-100.0%00.0%Multi-Sector ConglomeratesLANVIN GROUP HOLDINGS LIMITE$0$3,530 ▼-100.0%00.0%*W EXP 01/14/202Showing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
